Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J N Cooper

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bone Marrow Transplantation|November 21, 2007
Adoptive cellular immunotherapy for childhood malignanciesL J N Cooper
Cytotherapy|October 19, 2007
Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trialsD L DiGiusto, L J N Cooper
Leukemia|October 26, 2013
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitorsM A Kharfan-Dabaja, W G Wierda, L J N Cooper
Cancer Gene Therapy|January 17, 2015
Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptorH Singh, J S E Moyes, M H Huls, et al.
Cytotherapy|May 15, 2003
Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancyM C Jensen, L J N Cooper, A M Wu, et al.
Gene Therapy|August 15, 2015
Antithymidylate resistance enables transgene selection and cell survival for T cells in the presence of 5-fluorouracil and antifolatesD Rushworth, A Alpert, R Santana-Carrero, et al.
Gene Therapy|April 1, 2011
The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptorZ Jin, S Maiti, H Huls, et al.
Cytotherapy|May 16, 2006
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphomaL J N Cooper, L Ausubel, M Gutierrez, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bone Marrow Transplantation|November 21, 2007
Adoptive cellular immunotherapy for childhood malignanciesL J N Cooper
Cytotherapy|October 19, 2007
Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trialsD L DiGiusto, L J N Cooper
Leukemia|October 26, 2013
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitorsM A Kharfan-Dabaja, W G Wierda, L J N Cooper
Cancer Gene Therapy|January 17, 2015
Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptorH Singh, J S E Moyes, M H Huls, et al.
Cytotherapy|May 15, 2003
Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancyM C Jensen, L J N Cooper, A M Wu, et al.
Gene Therapy|August 15, 2015
Antithymidylate resistance enables transgene selection and cell survival for T cells in the presence of 5-fluorouracil and antifolatesD Rushworth, A Alpert, R Santana-Carrero, et al.
Gene Therapy|April 1, 2011
The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptorZ Jin, S Maiti, H Huls, et al.
Cytotherapy|May 16, 2006
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphomaL J N Cooper, L Ausubel, M Gutierrez, et al.
Pageof 1